Insulet Gross Margin 2010-2024 | PODD
Current and historical gross margin for Insulet (PODD) over the last 10 years. The current gross profit margin for Insulet as of June 30, 2024 is %.
| Insulet Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-06-30 | $1.87B | $1.29B | 68.94% |
| 2024-03-31 | $1.78B | $1.23B | 68.80% |
| 2023-12-31 | $1.70B | $1.16B | 68.32% |
| 2023-09-30 | $1.56B | $1.02B | 65.21% |
| 2023-06-30 | $1.47B | $0.91B | 62.14% |
| 2023-03-31 | $1.37B | $0.84B | 61.11% |
| 2022-12-31 | $1.31B | $0.81B | 61.69% |
| 2022-09-30 | $1.24B | $0.80B | 64.44% |
| 2022-06-30 | $1.18B | $0.80B | 68.08% |
| 2022-03-31 | $1.14B | $0.80B | 69.61% |
| 2021-12-31 | $1.10B | $0.75B | 68.52% |
| 2021-09-30 | $1.04B | $0.70B | 67.60% |
| 2021-06-30 | $1.00B | $0.66B | 66.73% |
| 2021-03-31 | $0.96B | $0.62B | 65.14% |
| 2020-12-31 | $0.90B | $0.58B | 64.49% |
| 2020-09-30 | $0.87B | $0.56B | 64.13% |
| 2020-06-30 | $0.83B | $0.53B | 63.88% |
| 2020-03-31 | $0.78B | $0.50B | 64.43% |
| 2019-12-31 | $0.74B | $0.48B | 65.04% |
| 2019-09-30 | $0.69B | $0.46B | 65.71% |
| 2019-06-30 | $0.65B | $0.44B | 66.62% |
| 2019-03-31 | $0.60B | $0.40B | 66.83% |
| 2018-12-31 | $0.56B | $0.37B | 65.60% |
| 2018-09-30 | $0.53B | $0.34B | 64.15% |
| 2018-06-30 | $0.50B | $0.31B | 62.28% |
| 2018-03-31 | $0.49B | $0.30B | 60.57% |
| 2017-12-31 | $0.47B | $0.28B | 59.78% |
| 2017-09-30 | $0.44B | $0.26B | 59.13% |
| 2017-06-30 | $0.41B | $0.24B | 58.64% |
| 2017-03-31 | $0.39B | $0.23B | 58.25% |
| 2016-12-31 | $0.37B | $0.21B | 57.49% |
| 2016-09-30 | $0.35B | $0.19B | 55.33% |
| 2016-06-30 | $0.32B | $0.17B | 52.01% |
| 2016-03-31 | $0.30B | $0.15B | 50.17% |
| 2015-12-31 | $0.26B | $0.13B | 50.76% |
| 2015-09-30 | $0.20B | $0.11B | 57.95% |
| 2015-06-30 | $0.20B | $0.12B | 59.80% |
| 2015-03-31 | $0.21B | $0.12B | 59.05% |
| 2014-12-31 | $0.23B | $0.13B | 55.41% |
| 2014-09-30 | $0.29B | $0.14B | 49.12% |
| 2014-06-30 | $0.27B | $0.13B | 47.60% |
| 2014-03-31 | $0.26B | $0.12B | 46.33% |
| 2013-12-31 | $0.25B | $0.11B | 45.34% |
| 2013-09-30 | $0.24B | $0.10B | 44.07% |
| 2013-06-30 | $0.23B | $0.10B | 43.91% |
| 2013-03-31 | $0.22B | $0.10B | 43.44% |
| 2012-12-31 | $0.21B | $0.09B | 42.92% |
| 2012-09-30 | $0.20B | $0.09B | 42.79% |
| 2012-06-30 | $0.19B | $0.08B | 42.41% |
| 2012-03-31 | $0.17B | $0.07B | 43.02% |
| 2011-12-31 | $0.15B | $0.07B | 44.74% |
| 2011-09-30 | $0.13B | $0.06B | 46.62% |
| 2011-06-30 | $0.11B | $0.06B | 48.67% |
| 2011-03-31 | $0.10B | $0.05B | 48.08% |
| 2010-12-31 | $0.10B | $0.04B | 45.36% |
| 2010-09-30 | $0.09B | $0.04B | 41.57% |
| 2010-06-30 | $0.08B | $0.03B | 37.35% |
| 2010-03-31 | $0.08B | $0.02B | 32.00% |
| 2009-12-31 | $0.07B | $0.02B | 27.27% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $16.665B | $1.697B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $198.609B | 25.65 |
| Stryker (SYK) | United States | $139.112B | 32.51 |
| Boston Scientific (BSX) | United States | $123.274B | 37.54 |
| Medtronic (MDT) | Ireland | $114.744B | 17.07 |
| EssilorLuxottica (ESLOY) | France | $106.116B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.707B | 34.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.203B | 0.00 |
| ResMed (RMD) | United States | $35.702B | 31.43 |
| Koninklijke Philips (PHG) | Netherlands | $29.054B | 22.08 |
| Terumo (TRUMY) | Japan | $28.562B | 40.34 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.656B | 13.63 |
| Baxter (BAX) | United States | $19.774B | 13.41 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.531B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.604B | 31.82 |
| Demant (WILYY) | Denmark | $9.197B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.682B | 32.48 |
| Lantheus Holdings (LNTH) | United States | $7.537B | 18.09 |
| ICU Medical (ICUI) | United States | $4.428B | 42.25 |
| TG Therapeutics (TGTX) | United States | $3.914B | 41.44 |
| Haemonetics (HAE) | United States | $3.842B | 19.01 |
| Neogen (NEOG) | United States | $3.799B | 39.84 |
| Perrigo (PRGO) | Ireland | $3.788B | 11.97 |
| GN Store Nord (GNNDY) | Denmark | $3.691B | 22.23 |
| Prestige Consumer Healthcare (PBH) | United States | $3.663B | 18.25 |
| Envista Holdings (NVST) | United States | $3.324B | 17.73 |
| QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
| Agios Pharmaceuticals (AGIO) | United States | $2.696B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.230B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.192B | 36.79 |
| LeMaitre Vascular (LMAT) | United States | $2.026B | 54.00 |
| AdaptHealth (AHCO) | United States | $1.520B | 10.97 |
| InMode (INMD) | Israel | $1.490B | 9.49 |
| Warby Parker (WRBY) | United States | $1.483B | 0.00 |
| AtriCure (ATRC) | United States | $1.403B | 0.00 |
| Owens & Minor (OMI) | United States | $1.237B | 9.55 |
| BioLife Solutions (BLFS) | United States | $1.187B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.110B | 0.00 |
| Evolus (EOLS) | United States | $1.037B | 0.00 |
| PetIQ (PETQ) | United States | $0.919B | 23.30 |
| Phibro Animal Health (PAHC) | United States | $0.908B | 18.83 |
| National Vision Holdings (EYE) | United States | $0.862B | 27.40 |
| Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
| Quanterix (QTRX) | United States | $0.594B | 0.00 |
| Surmodics (SRDX) | United States | $0.562B | 119.39 |
| ZimVie (ZIMV) | United States | $0.468B | 43.49 |
| VAREX IMAGING (VREX) | United States | $0.445B | 13.43 |
| Valneva SE (VALN) | France | $0.419B | 0.00 |
| Jin Medical (ZJYL) | China | $0.411B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.401B | 0.00 |
| Cerus (CERS) | United States | $0.339B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.335B | 0.00 |
| Biote (BTMD) | United States | $0.331B | 15.27 |
| OraSure Technologies (OSUR) | United States | $0.324B | 8.37 |
| Aurora Cannabis (ACB) | Canada | $0.315B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 31.08 |
| Zynex (ZYXI) | United States | $0.264B | 46.28 |
| Utah Medical Products (UTMD) | United States | $0.236B | 15.70 |
| Omeros (OMER) | United States | $0.234B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.221B | 0.00 |
| MacroGenics (MGNX) | United States | $0.213B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.172B | 71.33 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 20.74 |
| Brainsway (BWAY) | Israel | $0.137B | 163.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
| Veru (VERU) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.110B | 11.15 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.70 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.087B | 0.00 |
| InterCure (INCR) | Israel | $0.085B | 14.31 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| Safety Shot (SHOT) | United States | $0.076B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.62 |
| Exagen (XGN) | United States | $0.050B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 20.48 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |